We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $999B
1-Year Est. Return 46.22%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.24%
1 Year Est. Return
+46.22%
3 Year Est. Return
+150.45%
5 Year Est. Return
+185.95%
10 Year Est. Return
+1,389.53%
AUM
$463B
AUM Growth
+$17.5B
Cap. Flow
-$1.61B
Cap. Flow %
-0.35%
Top 10 Hldgs %
12.49%
Holding
2,596
New
97
Increased
1,091
Reduced
793
Closed
67

Sector Composition

Rank Sector Weight
1 Healthcare 16.95%
2 Consumer Discretionary 13.63%
3 Financials 12.8%
4 Industrials 12.27%
5 Technology 9.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WPG
1426
DELISTED
Washington Prime Group Inc.
WPG
$5.83M ﹤0.01%
+34,537
New +$6.01M
MASI
1427
DELISTED
Masimo
MASI
$5.81M ﹤0.01%
246,330
+14,600
+6% +$362K
HMIN
1428
DELISTED
HOMEINNS HOTEL GROUP SPONSORED ADR
HMIN
$5.76M ﹤0.01%
+168,411
New +$5.28M
AJRD
1429
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$5.75M ﹤0.01%
300,810
+8,800
+3% +$160K
BKE icon
1430
Buckle
BKE
$2.28B
$5.72M ﹤0.01%
128,962
+11,700
+10% +$534K
GTE icon
1431
Gran Tierra Energy
GTE
$337M
$5.7M ﹤0.01%
70,156
+6,370
+10% +$469K
LGND icon
1432
Ligand Pharmaceuticals
LGND
$5.78B
$5.67M ﹤0.01%
145,934
+16,030
+12% +$650K
IBTX
1433
DELISTED
Independent Bank Group, Inc.
IBTX
$5.67M ﹤0.01%
101,820
+800
+0.8% +$42.1K
ESSX
1434
DELISTED
ESSEX RENTAL CORP. COMMON STOCK
ESSX
$5.6M ﹤0.01%
2,302,904
+54,014
+2% +$152K
TTSH
1435
DELISTED
Tile Shop Holdings
TTSH
$5.58M ﹤0.01%
365,190
-28,710
-7% -$424K
DISH
1436
DELISTED
DISH Network Corp.
DISH
$5.55M ﹤0.01%
85,325
+7,502
+10% +$451K
AKAO
1437
DELISTED
Achaogen Inc
AKAO
$5.52M ﹤0.01%
395,400
+8,400
+2% +$118K
IQV icon
1438
IQVIA
IQV
$39.4B
$5.5M ﹤0.01%
103,200
+2,100
+2% +$106K
MBT
1439
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$5.45M ﹤0.01%
276,100
+14,000
+5% +$250K
PRFT
1440
DELISTED
Perficient Inc
PRFT
$5.42M ﹤0.01%
278,200
+54,300
+24% +$983K
ICUI icon
1441
ICU Medical
ICUI
$4.55B
$5.39M ﹤0.01%
88,700
+7,700
+10% +$455K
STRI
1442
DELISTED
STR HLDGS INC COM STK NEW (DE)
STRI
$5.29M ﹤0.01%
1,307,262
-292,069
-18% -$1.27M
PEGA icon
1443
Pegasystems
PEGA
$5.33B
$5.26M ﹤0.01%
498,400
+170,400
+52% +$1.63M
NVR icon
1444
NVR
NVR
$16.9B
$5.25M ﹤0.01%
4,563
-400
-8% -$446K
DDD icon
1445
3D Systems Corp
DDD
$620M
$5.15M ﹤0.01%
86,120
-127,244
-60% -$6.53M
DNY
1446
DELISTED
DONNELLEY R R & SONS CO
DNY
$5.14M ﹤0.01%
303,095
+4,000
+1% +$67.8K
UI icon
1447
Ubiquiti
UI
$35.2B
$5.14M ﹤0.01%
113,700
+39,100
+52% +$1.54M
RJF icon
1448
Raymond James Financial
RJF
$34.9B
$5.11M ﹤0.01%
150,944
-9,684
-6% -$323K
NES
1449
DELISTED
NUVERRA ENVIRONMENTAL INC NEW COM STK (DE)
NES
$5.1M ﹤0.01%
253,785
-30,724
-11% -$545K
UNT
1450
DELISTED
UNIT Corporation
UNT
$5M ﹤0.01%
72,700
+31,300
+76% +$2.04M

Similar funds

T. Rowe Price Associates's Q2 2014 Portfolio in Review

As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
  • T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
  • T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
  • T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
  • T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
  • T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
  • T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.

Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.